Skip to content

Entia Biosciences, Inc.: 10-Q filed 2011-11-14

What Entia Biosciences, Inc. reported in its quarterly report filed 2011-11-14 (fiscal Q3 2011): 26 published measures, 70 facts as tagged in accession 0001469709-11-000241.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-14
Fiscal period
fiscal Q3 2011
Accession
0001469709-11-000241 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Entia Biosciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-30405,345USD
At 2010-12-31442,542USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-09-30774,760USD
At 2010-12-31747,695USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-30-369,415USD
At 2010-12-31-305,153USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-09-307,971USD
At 2010-12-3165,061USD
At 2010-09-3061,046USD
At 2009-12-3148,141USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-200,793USD92
2011-01-01 to 2011-09-30-1,094,903USD273
2010-07-01 to 2010-09-30-428,849USD92
2010-01-01 to 2010-09-30-922,177USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-185,740USD273
2010-01-01 to 2010-09-30-404,738USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-07-01 to 2011-09-30108,566USD92
2011-01-01 to 2011-09-30309,309USD273
2010-07-01 to 2010-09-3096,705USD92
2010-01-01 to 2010-09-30295,737USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-09-30158,843USD273
2010-01-01 to 2010-09-30537,163USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-30,193USD273
2010-01-01 to 2010-09-30-119,520USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-30-3,408,177USD
At 2010-12-31-2,313,274USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-07-01 to 2011-09-3061,976,757shares92
2011-01-01 to 2011-09-3061,490,495shares273
2010-07-01 to 2010-09-3052,773,270shares92
2010-01-01 to 2010-09-3052,268,870shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-3035,916USD
At 2010-12-3143,217USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-125,343USD92
2011-01-01 to 2011-09-30-940,171USD273
2010-07-01 to 2010-09-30-361,182USD92
2010-01-01 to 2010-09-30-738,995USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-30260,289USD
At 2010-12-31317,253USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-30774,760USD
At 2010-12-31550,745USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2011-09-30109,140USD
At 2010-12-3180,994USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-3044,107USD
At 2010-12-3110,469USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-07-01 to 2011-09-30218,780USD92
2011-01-01 to 2011-09-301,148,735USD273
2010-07-01 to 2010-09-30418,243USD92
2010-01-01 to 2010-09-30911,389USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-09-30179,535USD
At 2010-12-31177,098USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-07-01 to 2011-09-3093,437USD92
2011-01-01 to 2011-09-30208,564USD273
2010-07-01 to 2010-09-3057,061USD92
2010-01-01 to 2010-09-30172,394USD273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-09-302,981,542USD
At 2010-12-311,959,462USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30101,318USD92
2011-01-01 to 2011-09-30377,820USD273
2010-07-01 to 2010-09-3094,918USD92
2010-01-01 to 2010-09-30220,525USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-09-3011,009USD273
2010-01-01 to 2010-09-304,502USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2011-07-01 to 2011-09-3075,451USD92
2011-01-01 to 2011-09-30154,732USD273
2010-07-01 to 2010-09-3067,667USD92
2010-01-01 to 2010-09-30183,182USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-11,433USD273
2010-01-01 to 2010-09-30-64,969USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-23,501USD273
2010-01-01 to 2010-09-30-2,451USD273

Inspect the source

Entity
Entia Biosciences, Inc. / CIK 0001408299
Captured
SEC response SHA-256
87eeafe4cf9625d2111221a4c2dc5d771c0e1669a38f86f588b6abe3fa046262

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001408299.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))